Search results for: 'd8aa intelligent pharma'

15 Sep 2022  |  Global  |  Market Research

Global Cyber Threat Intelligence (CTI) and Threat Intelligence Platform (TIP) Markets—Forecast to 2024

The Ever-evolving and Sophisticated Threat Landscape Fuels Demand for Threat Intelligence Solutions

Infographics

×

Threat intelligence is the collection, analysis, and operationalization of external and internal data about past, present, and future cyberattacks that organizations can leverage to understand their security environments and prevent threats. Frost & Sullivan identifies three segments in this broad market: cyber threat intelligence (CTI), threat...

This Frost & Sullivan research examines the growing need for artificial intelligence (AI) services to help businesses meet key goals and objectives, as well as the strategic position of public cloud service providers to develop and launch successful AI capabilities for customers. The report discusses the importance of public cloud providers in the ...

The biopharma industry has been evolving over the past few decades. This study analyses the top ten trends that will impact the future of the biopharma industry through 2040.The future of biopharma will be driven by innovation in AI and ML, particularly generative AI, and by advancements in translational medicine and synthetic biology. Future clini...

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...

The need to adopt threat intelligence (TI) has transcended compliance requirements it is now essential due to the evolving threat landscape. Organizations must integrate TI into their IT frameworks to operate effectively. Global digitalization initiatives such as cloud migration, IoT, AI, and remote work have expanded attack surfaces, IT complexity...

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...

Intelligence- and data-driven decision-making have quickly emerged as core competencies that drive an organization s security strategies to safeguard the people, assets, and data for which they are responsible. Ongoing convergence between physical and digital security systems, the influx of new analytics to inform operational decisions, and digital...

The modern threat landscape has undergone a profound transformation, driven by the global push toward digitalization. This has led to expanded attack surfaces, heightened IT complexity, and increased risks in supply chains. Today, threat actors launch multivector attacks that target organizations internal networks and their external digital assets...

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...